Comparison of Alcohol Treatment and Costs After Implementation of Medicaid Managed CareByAileen B. Rothbard, ScD,Eri Kuno, PhDMay 1st 2006
Labor Characteristics and Program Costs of a Successful Diabetes Disease Management ProgramByRussell L. Rothman, MD, MPP,Stephanie A. So, PhD,John Shin, BS,Robert M. Malone, PharmD,Betsy Bryant, PharmD,Darren A. DeWalt, MD, MPH,Michael P. Pignone, MD, MPH,Robert S. Dittus, MD, MPHMay 1st 2006
Monitoring of Drugs With a Narrow Therapeutic Range in Ambulatory CareByMarsha A. Raebel, PharmD,Nikki M. Carroll, MS,Susan E. Andrade, ScD,Elizabeth A. Chester, PharmD,Jennifer Elston Lafata, PhD,Adrianne Feldstein, MD,Margaret J. Gunter, PhD,Winnie W. Nelson, PharmD,Steven R. Simon, MD, MPH,K. Arnold Chan, MD, ScD,Robert L. Davis, MD, MPH,Richard Platt, MDMay 1st 2006
Value in Development of Complex InterventionsByAnne E. Sales, PhD, RN,Christian D. Helfrich, MPH, PhDMay 1st 2006
Controlling Adverse Drug Reactions Through Improved MonitoringByPatrick J. McDonnell, PharmDMay 1st 2006
Development of a Complex Intervention for Secondary Prevention of Coronary Heart Disease in Primary Care Using the UK Medical Research Council FrameworkByMolly Byrne, PhD,Margaret E. Cupples, MD,Susan M. Smith, MD,Claire Leathem, BSc,Mairé,ad Corrigan, PhD,Mary C. Byrne, PhD,Andrew W. Murphy, MDMay 1st 2006
